| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 17 | 19 | 21 | 32 | 25 | 30 | 38 | 32 | 37 | 39 | 37 | 50 | 48 | 51 | 54 | 56 | 61 | 75 | 93 | 105 | 117 | 137 | 142 | 138 | 134 | 174 | 163 | 1,314 | 161 | 197 | 260 | 285 | 322 | 348 | 368 | 395 | 325 | 299 | 296 | 270 | 308 | 324 | 307 | 359 | 388 |
| Expenses | 22 | 23 | 28 | 38 | 35 | 36 | 41 | 38 | 41 | 44 | 39 | 45 | 52 | 56 | 60 | 65 | 75 | 89 | 105 | 116 | 132 | 137 | 144 | 141 | 141 | 178 | 169 | 156 | 194 | 222 | 269 | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 468 | 307 | 311 | 292 | 324 | 356 | 400 |
| EBITDA | -6 | -4 | -7 | -5 | -10 | -6 | -3 | -5 | -4 | -5 | -2 | 5 | -4 | -5 | -7 | -8 | -14 | -14 | -12 | -11 | -15 | 0 | -2 | -2 | -7 | -4 | -6 | 1,158 | -33 | -25 | -8 | -6 | -3 | 21 | 13 | 24 | 8 | 26 | -172 | -38 | -3 | 31 | -17 | 3 | -12 |
| Operating Profit % | -43 % | -27 % | -37 % | -18 % | -43 % | -23 % | -9 % | -18 % | -19 % | -14 % | -8 % | -3 % | -11 % | -13 % | -13 % | -19 % | -24 % | -19 % | -13 % | -12 % | -14 % | -0 % | -2 % | -2 % | -6 % | -3 % | -6 % | -9 % | -24 % | -16 % | -6 % | -4 % | -4 % | 3 % | 1 % | 1 % | -3 % | -1 % | -71 % | -9 % | -9 % | 2 % | -8 % | -3 % | -7 % |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Profit Before Tax | -8 | -6 | -9 | -8 | -13 | -8 | -5 | -8 | -7 | -7 | -4 | 3 | -5 | -7 | -9 | -11 | -16 | -16 | -14 | -12 | -16 | -1 | -3 | -4 | -9 | -6 | -8 | 1,157 | -34 | -26 | -11 | -9 | -6 | 19 | 11 | 21 | 5 | 25 | -174 | -39 | -5 | 30 | -19 | 1 | -15 |
| Tax | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | -5 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 1 | 1 | 133 | -8 | -1 | -8 | 18 | 42 | 19 | 23 | 24 | -17 | -16 | -19 | -1 | -22 | 4 | -3 | 1 | -2 |
| Net Profit | -6 | -6 | -9 | -8 | -12 | -9 | -5 | -8 | -7 | -7 | -4 | 2 | -5 | -7 | -9 | -11 | -16 | -10 | -14 | -12 | -15 | -1 | -4 | -4 | -9 | -6 | -9 | 1,024 | -26 | -25 | -3 | -26 | -48 | -0 | -12 | -3 | 22 | 41 | -155 | -38 | 18 | 27 | -15 | 0 | -13 |
| EPS in ₹ | -1.96 | -1.91 | -2.83 | -2.43 | -3.80 | -2.69 | -1.67 | -2.43 | -2.24 | -2.20 | -0.97 | -0.68 | -1.33 | -1.92 | -2.47 | -3.02 | -4.39 | -2.62 | -3.82 | -2.69 | -3.06 | -0.04 | -0.70 | -0.63 | -1.90 | -1.14 | -1.43 | 232.31 | -6.07 | -6.24 | -0.39 | -6.00 | -10.75 | 0.41 | -2.55 | -0.23 | 5.17 | 9.79 | -34.40 | -8.47 | 4.30 | 7.52 | -3.99 | 0.35 | -3.51 |
Health X Platform
Health X Platform
316.20
-1.45
(-0.46%)
Market Cap
1,005.85 Cr
PE Ratio
-702.67
Volume
2,653.00
Day High - Low
318.90 - 315.00
52W High-Low
363.00 - 252.50
Key Fundamentals
Market Cap
1,005.85 Cr
EPS
0.37
PE Ratio
-702.67
PB Ratio
1.57
Book Value
201.47
EBITDA
-53.24
Dividend Yield
0.00 %
Industry
Healthcare Services Sector
Healthcare Service Provider Return on Equity
-15.45
Debt to Equity
0.00
Actual
Company News
View All News
Health X Platform Ltd held a conference call on June 12, 2026, to discuss Q4 FY26 performance. The audio recording is now available on the company website.
Health X Platform approves composite scheme
10 days ago
10 days agoHealth X Platform Limited approved a composite scheme involving demerger and amalgamation with multiple entities. The scheme defines share exchange ratios and appointed date.
Promoter Ravi Kant Sharma sells 2.5 lakh sharesJun 05, 2026
Jun 05, 2026Ravi Kant Sharma sold 2,50,000 shares of Health X Platform Limited for Rs. 7,49,77,528.94 via market sale on June 3, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,635.80 | #1 27,408.65 | 54.59 | #1 2,762.90 | 8.15 | #1 510 | -14.98 | 58.22 | |
1,364.20 | 14,037.17 | 77.57 | 814.20 | 16.36 | 182 | 37.25 | 63.27 | |
552.75 | 11,460.04 | 58.71 | 1,645.85 | 22.25 | 185 | 74.66 | 60.85 | |
540.55 | 8,603.68 | 52.21 | 846.00 | 20.48 | 163 | #1 125.46 | 66.68 | |
733.75 | 7,362.50 | 94.37 | 998.85 | 29.74 | 62 | 22.09 | 64.98 | |
531.30 | 1,723.47 | #1 17.04 | 772.77 | 4.05 | 106 | 101.45 | 37.04 | |
268.35 | 1,397.59 | 43.40 | 310.41 | 21.30 | 34 | -13.89 | 42.01 | |
665.95 | 1,301.48 | 19.52 | 498.18 | #1 237.06 | 69 | 65.45 | 65.01 | |
1,196.10 | 1,026.57 | 17.22 | 141.92 | 27.17 | 61 | 22.50 | 46.35 | |
316.20 | #10 1,005.85 | #10 -702.67 | #3 1,319.27 | #8 12.68 | #10 -3 | #10 -173.86 | 61.79 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
12.68 %
Net Income Growth
-97.63 %
Cash Flow Change
-148.27 %
ROE
-2,718.64 %
ROCE
750.91 %
EBITDA Margin (Avg.)
-1,269.70 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 281 | 256 | 251 | 236 | 231 | 316 | 293 | 1,278 | 1,206 | 1,150 | 974 | 936 |
| Fixed Assets | 138 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 82 |
| Current Assets | 88 | 90 | 108 | 95 | 66 | 137 | 131 | 508 | 575 | 354 | 267 | 218 |
| Capital Work in Progress | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 4 | 1 | 8 | 28 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 145 |
| Other Assets | 137 | 129 | 119 | 89 | 77 | 146 | 139 | 518 | 585 | 363 | 287 | 0 |
| Total Equity & Liabilities | 281 | 256 | 251 | 236 | 231 | 316 | 293 | 1,278 | 1,206 | 1,150 | 974 | 936 |
| Current Liabilities | 22 | 31 | 49 | 27 | 22 | 66 | 60 | 68 | 110 | 79 | 105 | 130 |
| Non Current Liabilities | 4 | 7 | 7 | 5 | 8 | 3 | 3 | 116 | 102 | 72 | 5 | 41 |
| Total Equity | 255 | 218 | 195 | 203 | 200 | 246 | 229 | 1,094 | 994 | 1,000 | 865 | 641 |
| Reserve & Surplus | 223 | 186 | 158 | 144 | 106 | 173 | 163 | 790 | 717 | 726 | 638 | 609 |
| Share Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | -0 | 7 | -2 | -6 | 11 | -5 | 1 | 19 | -0 | -19 |
| Investing Activities | 7 | -1 | 4 | 15 | -2 | -22 | 21 | 220 | 133 | -34 | -1 |
| Operating Activities | -12 | -12 | -2 | -49 | -30 | -69 | -31 | -207 | -112 | 36 | -17 |
| Financing Activities | 4 | 13 | 5 | 33 | 26 | 103 | 4 | -11 | -2 | -2 | -0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 74.43 % | 74.43 % | 74.43 % | 73.72 % | 73.72 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.92 % | 73.94 % | 74.11 % | 74.24 % | 74.24 % | 74.69 % | 74.84 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.32 % | 0.49 % | 0.56 % | 0.61 % | 0.99 % | 1.71 % | 1.60 % | 1.88 % | 2.04 % | 2.25 % | 2.17 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.09 % | 0.09 % | 0.09 % | 0.17 % | 0.17 % | 0.86 % | 0.96 % | 1.35 % | 1.98 % | 1.85 % | 2.06 % | 2.09 % | 2.07 % | 2.07 % | 2.60 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 11.41 % | 13.05 % | 13.03 % | 13.80 % | 14.49 % | 14.70 % | 15.01 % | 15.24 % | 15.09 % | 15.17 % | 15.64 % | 16.52 % | 16.06 % | 15.05 % | 14.47 % | 14.09 % | 13.70 % | 13.35 % | 12.84 % | 12.72 % | 12.25 % |
| Others | 14.16 % | 12.52 % | 12.55 % | 12.48 % | 11.79 % | 11.38 % | 10.98 % | 10.76 % | 10.90 % | 10.74 % | 9.95 % | 8.20 % | 8.51 % | 9.07 % | 8.63 % | 8.41 % | 8.52 % | 8.44 % | 8.81 % | 8.27 % | 8.15 % |
| No of Share Holders | 11,797 | 13,034 | 13,090 | 14,276 | 15,174 | 15,247 | 15,554 | 15,166 | 15,088 | 14,752 | 14,633 | 14,053 | 14,544 | 14,493 | 15,360 | 14,093 | 13,693 | 13,452 | 13,012 | 12,287 | 11,845 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 27 Sept 2016 |  Change Of Name | NA | 27 Sept 2016 | 0.00 | 0.00 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 307.85 | 306.45 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 335.25 | 319.50 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 282.35 | 275.00 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 269.90 | 265.45 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 284.40 | 292.65 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 271.55 | 307.40 |
| 13 Nov 2025 | Quarterly Result Announcement | NA | 13 Nov 2025 | 298.55 | 289.55 |
| 06 Feb 2026 | Quarterly Result Announcement | NA | 06 Feb 2026 | 301.15 | 299.70 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 285.95 | 307.25 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Scheme of Arrangement10 days ago
10 days agoBoard Meeting Outcome for Intimation Of The Outcome Of The Meeting Of The Board Of Directors Of The Company Held On June 10 2026 Under Regulation 30 Of The SEBI (LODR) Reg 201510 days ago
10 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 06, 2026
Jun 06, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Jun 05, 2026
Jun 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 02, 2026
Jun 02, 2026Announcement Under Reg 30 (LODR) - Intimation For Change Of Website Of The CompanyJun 02, 2026
Jun 02, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2026
May 30, 2026Results - Financial Results For The Quarter And Year Ended March 31 2026May 30, 2026
May 30, 2026Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held On May 30 2026May 30, 2026
May 30, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
May 28, 2026Board Meeting Intimation for Meeting Of The Board Of Directors To Be Held On 30Th May 2026May 22, 2026
May 22, 2026Disclosure Under Reg 30 (LODR) Reg 2015 - Intimation Of Completion Of Transfer By Sastasundar Healthbuddy Limited Material Subsidiary Of The CompanyMay 15, 2026
May 15, 2026Approval From Stock Exchange For Change In Name And SymbolApr 25, 2026
Apr 25, 2026Update On Application To Stock Exchanges For Change In Name Of The CompanyApr 24, 2026
Apr 24, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Apr 01, 2026
Apr 01, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 28, 2026
Mar 28, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 27, 2026
Mar 27, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 23, 2026
Mar 23, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Mar 16, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 16, 2026
Mar 16, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Mar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Mar 05, 2026Disclosure under Regulation 30A of LODRFeb 27, 2026
Feb 27, 2026Disclosure Under Reg 30(9) Of SEBI (LODR) - Intimation By Sastasundar Healthbuddy Limited Material Subsidiary Regarding Outcome Of Its Board MeetingFeb 27, 2026
Feb 27, 2026Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board Of DirectorsFeb 27, 2026
Feb 27, 2026Disclosure Under Reg 30 (LODR) - Intimation By Sastasundar Healthbuddy Limited Material Subsidiary Regarding Outcome Of Its Board MeetingFeb 26, 2026
Feb 26, 2026Board Meeting Outcome for Disclosure Under Reg 30 Of SEBI (LODR) - Outcome Of Meeting Of The Board Of DirectorsFeb 26, 2026
Feb 26, 2026Disclosure Under Reg 30 Of SEBI (LODR) Reg - Execution Of Share Purchase Agreement By Sastasundar Healthbuddy Limited Material Subsidiary Of The CompanyFeb 25, 2026
Feb 25, 2026Announcement under Regulation 30 (LODR)-Change of Company NameFeb 20, 2026
Feb 20, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Feb 20, 2026
Feb 20, 2026Disclosure Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Reg 2015Feb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 16, 2026
Feb 16, 2026Disclosure Under Reg 30 - Update On The Reduction Of Share Capital Of Step-Down Subsidiary Of The CompanyFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationFeb 13, 2026
Feb 13, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 13, 2026
Feb 13, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2026
Feb 07, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2026
Feb 06, 2026Results - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025Feb 06, 2026
Feb 06, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 6Th February 2026Feb 06, 2026
Feb 06, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.02% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 61.79
ATR(14)
Less Volatile 13.13
STOCH(9,6)
Neutral 65.67
STOCH RSI(14)
Overbought 98.39
MACD(12,26)
Bullish 1.59
ADX(14)
Strong Trend 32.02
UO(9)
Bearish 47.84
ROC(12)
Uptrend And Accelerating 4.67
WillR(14)
Neutral -27.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
